| GLP-3R | Not named | Not namedReta / LY3437943 is an investigational GLP-1/GIP/glucagon agonist. It is not named in the NCAA public guidance or WADA 2026 Prohibited List; that absence is not an NCAA approval or an eligibility clearance. | Not named · S0 if unapproved | 251 |
|---|
| GLP-2T | Not named | Not namedDual GIP/GLP-1 agonist. Markers of GLP-2T are on WADA's 2026 Monitoring Program, but the substance is not prohibited. NCAA does not explicitly list it. | Monitoring only | 210 |
|---|
| BPC-157 | Banned | Named by NCAAExplicitly named on NCAA Banned Drugs List (added 2023) under Peptide Hormones, Growth Factors & Mimetics. | S0 · named | 243 |
|---|
| TB-500 | Banned | Named by NCAAExplicitly named on NCAA Banned Drugs List under Peptide Hormones, Growth Factors & Mimetics. | S2 · named | 206 |
|---|
| MOTS-c | Banned | Class-basedMitochondrial-derived peptide and AMPK activator. Not named by the NCAA, but WADA names MOTS-c in S4.4.1 as a metabolic modulator, a clear fit for the NCAA hormone and metabolic modulators class. | S4 · named | 253 |
|---|
| NAD+ | Not named | Not namedNicotinamide adenine dinucleotide. Not on NCAA or WADA prohibited list. | Not named · IV limit (M2.2) | 227 |
|---|
| Semax | Not named | Not namedRussian nootropic heptapeptide (ACTH 4-7 analog); not on NCAA or WADA prohibited list. Catchall risk low given non-anabolic mechanism. | Not named | 205 |
|---|
| Selank | Not named | Not namedRussian anxiolytic heptapeptide; not on NCAA or WADA prohibited list. | Not named | 199 |
|---|
| CJC-1295 (With DAC) | Banned | Class-basedLong-acting GHRH analog; WADA S2.2.4 explicitly lists CJC-1295. Banned under NCAA catchall. | S2 · named | 73 |
|---|
| Tesamorelin | Banned | Class-basedGHRH analog (FDA-approved for HIV lipodystrophy); WADA S2.2.4 explicitly lists tesamorelin. Banned under NCAA catchall. | S2 · named | 235 |
|---|
| Ipamorelin | Banned | Class-basedGrowth hormone secretagogue; WADA S2.2.4 explicitly lists ipamorelin. NCAA catchall covers GH secretagogues as related to hGH. | S2 · named | 195 |
|---|
| Melanotan-1 (MT-1) | Not named | Not namedAlpha-MSH analog; not explicitly listed by NCAA or WADA. Not a known performance enhancer; catchall unlikely to apply. | Not named | 108 |
|---|
| Glutathione | Not named | Not namedTripeptide antioxidant. Not on NCAA or WADA prohibited list. | Not named · IV limit (M2.2) | 145 |
|---|
| GLP-1S | Not named | Not namedGLP-1 agonist. Markers of GLP-1S are on WADA's 2026 Monitoring Program, but the substance is not prohibited. NCAA does not explicitly list it. | Monitoring only | 140 |
|---|
| Cagrilintide | Not named | Not namedLong-acting amylin analog. Not named on the NCAA list or WADA 2026 Prohibited List, but it has no regulatory approval, so WADA S0 (non-approved substances) prohibits it at all times. Treat as not cleared. | Not named · S0 if unapproved | 133 |
|---|
| Sermorelin | Banned | Class-basedGHRH analog (first 29 aa); WADA S2.2.4 explicitly lists sermorelin. Banned under NCAA catchall. | S2 · named | 125 |
|---|
| IGF-1 LR3 | Banned | Class-basedIGF-1 analog; NCAA explicitly names IGF-1 under Peptide Hormones, Growth Factors & Mimetics. | S2 · named | 122 |
|---|
| GHK-Cu (Copper Peptide) | Not named | Not namedCopper tripeptide-1, used topically for skin/hair. Not on NCAA or WADA prohibited list. If injected systemically, catchall risk is low but theoretical. | Not named | 259 |
|---|
| Thymosin Alpha-1 | Not named | Not namedImmunomodulatory thymic peptide (FDA-approved for hepatitis B in some countries). NOT the same as Thymosin-β4 (TB-500). Not explicitly listed by NCAA or WADA. | Not named | 124 |
|---|
| Eloralintide | Not named | Not namedInvestigational amylin agonist not approved for human therapeutic use; WADA S0 (non-approved substances) catchall risk — verify current list. | Not named · S0 if unapproved | 11 |
|---|
| GLOW | Banned | Blend: strictest partBlend of BPC-157, TB-500 and GHK-Cu. BPC-157 and TB-500 are both named in the NCAA peptide hormones, growth factors, related substances and mimetics class, so the blend is banned. | S0 · named | 198 |
|---|
| KLOW Protocol | Banned | Blend: strictest partBlend of BPC-157, TB-500, GHK-Cu and KPV. BPC-157 and TB-500 are both named in the NCAA peptide hormones, growth factors, related substances and mimetics class, so the blend is banned. | S0 · named | 205 |
|---|
| Wolverine | Banned | Blend: strictest partBlend of BPC-157 and TB-500, both named in the NCAA peptide hormones, growth factors, related substances and mimetics class, so the blend is banned. | S0 · named | 185 |
|---|
| CagriSema (Cagrilintide + GLP-1S) | Not named | Not namedAmylin-analog/GLP-1 combination. Not named on the NCAA list or the WADA 2026 Prohibited List, but the cagrilintide component is unapproved (CagriSema is under FDA review, not approved), so WADA S0 (non-approved substances) prohibits it at all times. Treat as not cleared. | Not named · S0 if unapproved | 17 |
|---|
| Liraglutide | Not named | Not namedGLP-1 agonist (FDA-approved Saxenda/Victoza). Not named on the NCAA or WADA 2026 Prohibited List. | Not named | 1 |
|---|
| Dulaglutide | Not named | Not namedGLP-1 agonist. Not named on the NCAA or WADA 2026 Prohibited List. | Not named | Not sold |
|---|
| AOD-9604 | Banned | Class-basedModified hGH fragment 177-191; banned under NCAA growth hormone entry / WADA S2.1 GH and releasing factors. | S2 · named | 134 |
|---|
| HGH 191AA (Somatropin) | Banned | Named by NCAAExplicitly named (Growth hormone/hGH) on NCAA Banned Drugs List under Peptide Hormones, Growth Factors & Mimetics. | S2 · named | 9 |
|---|
| CJC-1295 (No DAC) | Banned | Class-basedModified GHRH; WADA S2.2.4 explicitly lists CJC-1295. Banned under NCAA catchall (GHRH analog). | S2 · named | 127 |
|---|
| GHRP-6 | Banned | Class-basedGrowth hormone releasing peptide; WADA S2.2.4 explicitly lists GHRP-6. Banned under NCAA catchall. | S2 · named | 40 |
|---|
| GHRP-2 | Banned | Class-basedGrowth hormone releasing peptide (pralmorelin); WADA S2.2.4 explicitly lists GHRP-2. Banned under NCAA catchall. | S2 · named | 34 |
|---|
| Hexarelin | Banned | Class-basedGHRP (examorelin); WADA S2.2.4 explicitly lists hexarelin. Banned under NCAA catchall. | S2 · named | 33 |
|---|
| IGF-DES (IGF-1 DES[1-3]) | Banned | Class-basedIGF-1 analog; NCAA explicitly names IGF-1 under Peptide Hormones, Growth Factors & Mimetics. | S2 · named | 3 |
|---|
| MGF (Mechano Growth Factor) | Banned | Class-basedIGF-1 splice variant; NCAA IGF-1 entry plus WADA S2.3 explicitly lists Mechano growth factors (MGFs). | S2 · named | 7 |
|---|
| PEG-MGF | Banned | Class-basedPegylated MGF; covered by NCAA IGF-1 entry and WADA S2.3 Mechano growth factors. | S2 · named | 17 |
|---|
| Follistatin-344 | Banned | Class-basedMyostatin inhibitor; WADA S4.5 prohibits myostatin-pathway modulators. NCAA catchall applies. | S4 · named | 4 |
|---|
| Testosterone Cypionate | Banned | Named by NCAATestosterone explicitly named on NCAA Banned Drugs List under Anabolic Agents. No TUE for athletic use — doctor's prescription is insufficient. | S1 · named | Not sold |
|---|
| Sustanon 250 | Banned | Named by NCAATestosterone ester blend; explicitly banned under NCAA Anabolic Agents. | S1 · named | Not sold |
|---|
| Trenbolone Acetate | Banned | Named by NCAATrenbolone explicitly named on NCAA Banned Drugs List under Anabolic Agents. | S1 · named | Not sold |
|---|
| EPO (Erythropoietin) | Banned | Named by NCAAExplicitly named on NCAA Banned Drugs List under Peptide Hormones, Growth Factors & Mimetics. | S2 · named | Not sold |
|---|
| Dihexa | Not named | Not namedAngiotensin IV-derived nootropic hexapeptide; not on NCAA or WADA prohibited list.WADA: Not FDA-approved for human therapeutic use. WADA's S0 (Non-Approved Substances) category broadly covers unapproved investigational compounds like this one, even though it is not individually named on the Prohibited List. | Not named · S0 if unapproved | 16 |
|---|
| Cerebrolysin | Banned | Class-basedPorcine brain-derived peptide mixture containing neurotrophic growth factors. NCAA's own examples already extend the growth-factor class to non-isolated biological extracts (IGF-1 via colostrum or deer antler velvet), so this fits the Peptide Hormones, Growth Factors & Mimetics catchall. | Not named · S2 may apply | 19 |
|---|
| P21 Peptide | Not named | Not namedCNTF-derived neurogenesis research peptide; not on NCAA or WADA prohibited list.WADA: Not FDA-approved for human therapeutic use. WADA's S0 (Non-Approved Substances) category broadly covers unapproved investigational compounds like this one, even though it is not individually named on the Prohibited List. | Not named · S0 if unapproved | 6 |
|---|
| Epithalon (Epitalon) | Not named | Not namedTetrapeptide telomerase activator (Russian research); not on NCAA or WADA prohibited list. Catchall risk low — no class fit.WADA: Not FDA-approved for human therapeutic use. WADA's S0 (Non-Approved Substances) category broadly covers unapproved investigational compounds like this one, even though it is not individually named on the Prohibited List. | Not named · S0 if unapproved | 159 |
|---|
| FOXO4-DRI | Not named | Not namedSenolytic D-retro-inverso research peptide; not on NCAA or WADA prohibited list.WADA: Not FDA-approved for human therapeutic use. WADA's S0 (Non-Approved Substances) category broadly covers unapproved investigational compounds like this one, even though it is not individually named on the Prohibited List. | Not named · S0 if unapproved | 32 |
|---|
| Humanin | Not named | Not namedMitochondrial-derived cytoprotective peptide; not on NCAA or WADA prohibited list. Mechanism overlaps with MOTS-c but less characterized — catchall risk exists.WADA: Not FDA-approved for human therapeutic use. WADA's S0 (Non-Approved Substances) category broadly covers unapproved investigational compounds like this one, even though it is not individually named on the Prohibited List. | Not named · S0 if unapproved | 8 |
|---|
| SS-31 (Elamipretide) | Not named | Not namedElamipretide is not named in the NCAA examples. FDA granted accelerated approval to Forzinity (elamipretide) on September 19, 2025, so it should not be described as an unapproved WADA S0 substance; exact NCAA eligibility still requires product review because the NCAA list is class-based. | Not named | 168 |
|---|
| Melanotan-2 (MT-2) | Not named | Not namedAlpha-MSH analog; not explicitly listed. Some sources argue catchall via nebulous 'anabolic' tanning claims; consensus is not banned.WADA: Not FDA-approved for human therapeutic use. WADA's S0 (Non-Approved Substances) category broadly covers unapproved investigational compounds like this one, even though it is not individually named on the Prohibited List. | Not named · S0 if unapproved | 202 |
|---|
| Snap-8 | Not named | Not namedTopical cosmetic acetyl octapeptide-3 (SNAP-25 mimic). Not on NCAA or WADA prohibited list. | Not named | 60 |
|---|
| Matrixyl (Palmitoyl Pentapeptide-4) | Not named | Not namedTopical cosmetic collagen-signaling peptide. Not on NCAA or WADA prohibited list. | Not named | 3 |
|---|
| L-Carnitine (Injectable) | Not named | Not namedAmino acid derivative. Oral/IM use is permitted; WADA only prohibits IV infusion >100 mL / 12 hr as a prohibited METHOD (M2), not the substance itself. | Not named · IV limit (M2.2) | 18 |
|---|
| Vitamin B12 (Injectable) | Not named | Not namedEssential vitamin (cyanocobalamin). Not on NCAA or WADA prohibited list. | Not named · IV limit (M2.2) | 11 |
|---|
| Oxytocin | Not named | Not namedPosterior pituitary hormone. Not listed by NCAA/WADA. | Not named | 54 |
|---|
| PT-141 (Bremelanotide) | Not named | Not namedFDA-approved melanocortin agonist (hypoactive sexual desire). Not explicitly listed by NCAA/WADA; catchall application is disputed but not enforced. | Not named | 178 |
|---|
| Kisspeptin-10 | Banned | Class-basedUpstream stimulator of GnRH/LH release; NCAA catchall applies as LH/testosterone mimetic pathway. | S2 · named | 129 |
|---|
| HGH Fragment 176-191 | Banned | Class-basedhGH C-terminal fragment; covered by NCAA growth hormone entry and WADA S2.1. | S2 · named | 16 |
|---|
| HCG (Human Chorionic Gonadotropin) | Banned | Named by NCAAExplicitly named on NCAA Banned Drugs List under Peptide Hormones, Growth Factors & Mimetics (stimulates endogenous testosterone in males). | S2 · named | 36 |
|---|
| Insulin (Pharmaceutical) | Not named | Named exceptionNCAA's current guidance explicitly lists insulin as an exception that is not banned. WADA rules differ, so athletes in another testing pool must check the rules that apply to them. | S4 · named | Not sold |
|---|
| 5-Amino-1MQ | Not named | Not namedNNMT inhibitor; not explicitly listed by NCAA or WADA, but metabolic-modulator catchall could apply given performance-enhancement claims.WADA: Not FDA-approved for human therapeutic use. WADA's S0 (Non-Approved Substances) category broadly covers unapproved investigational compounds like this one, even though it is not individually named on the Prohibited List. | Not named · S0 if unapproved | 151 |
|---|
| AICAR | Banned | Class-basedAMPK activator; WADA S4.4 explicitly lists AICAR as a prohibited metabolic modulator. NCAA catchall applies. | S4 · named | 15 |
|---|
| DSIP (Delta Sleep-Inducing Peptide) | Not named | Not namedResearch nonapeptide; not on NCAA or WADA prohibited list. No known performance enhancement mechanism.WADA: Not FDA-approved for human therapeutic use. WADA's S0 (Non-Approved Substances) category broadly covers unapproved investigational compounds like this one, even though it is not individually named on the Prohibited List. | Not named · S0 if unapproved | 159 |
|---|
| SLU-PP-332 | Banned | Class-basedPan-ERR agonist sold as an exercise mimetic. Not named by the NCAA or WADA, but its claimed effect is the one the NCAA hormone and metabolic modulators class targets with its named PPAR-δ example (GW1516 / Cardarine), so it fits that class. | Not named · S0 if unapproved | 29 |
|---|
| KPV | Not named | Not namedAlpha-MSH tripeptide fragment; not listed by NCAA or WADA, not a performance enhancer.WADA: Not FDA-approved for human therapeutic use. WADA's S0 (Non-Approved Substances) category broadly covers unapproved investigational compounds like this one, even though it is not individually named on the Prohibited List. | Not named · S0 if unapproved | 196 |
|---|
| Melatonin (Injectable) | Not named | Not namedPineal hormone sleep aid. Not on NCAA or WADA prohibited list. | Not named | 1 |
|---|
| Lipo-C / Lipo-B Injectable Blend | Not named | Not namedCompounded B-vitamin + amino acid weight-loss blend (methionine/inositol/choline/B12). Components not on NCAA or WADA prohibited list. | Not named · IV limit (M2.2) | 9 |
|---|
| Adipotide (FTPP) | Banned | Class-basedPro-apoptotic prohibitin-targeted weight loss peptide; catchall applies under hormone/metabolic-modulator class given claimed adipose-specific action (falls within 'mimetics' clause). | Not named · S0 if unapproved | 5 |
|---|
| LL-37 | Not named | Not namedCathelicidin antimicrobial peptide; not on NCAA or WADA prohibited list.WADA: Not FDA-approved for human therapeutic use. WADA's S0 (Non-Approved Substances) category broadly covers unapproved investigational compounds like this one, even though it is not individually named on the Prohibited List. | Not named · S0 if unapproved | 49 |
|---|
| ARA-290 (Cibinetide) | Banned | Class-basedEPO-derived innate repair receptor agonist; WADA S2 extends to EPO-receptor agonists and mimetics. NCAA catchall applies. | S2 · class | 58 |
|---|
| Lemon Bottle (Lipolytic Injection) | Not named | Not namedProprietary lipolytic blend (riboflavin + bromelain + lecithin, composition varies). Not on NCAA or WADA prohibited list. Component review recommended before use. | Not named | Not sold |
|---|
| PE-22-28 | Not named | Not namedSpadin analog antidepressant research peptide; not on NCAA or WADA prohibited list.WADA: Not FDA-approved for human therapeutic use. WADA's S0 (Non-Approved Substances) category broadly covers unapproved investigational compounds like this one, even though it is not individually named on the Prohibited List. | Not named · S0 if unapproved | 16 |
|---|
| VIP (Vasoactive Intestinal Peptide) | Not named | Not named28-aa neuropeptide; not on NCAA or WADA prohibited list. Secretin/glucagon family — therapeutic research only.WADA: Not FDA-approved for human therapeutic use. WADA's S0 (Non-Approved Substances) category broadly covers unapproved investigational compounds like this one, even though it is not individually named on the Prohibited List. | Not named | 54 |
|---|
| Hyaluronic Acid (Injectable) | Not named | Not namedJoint viscosupplement / dermal filler. Not on NCAA or WADA prohibited list. | Not named | Not sold |
|---|
| Thymalin | Not named | Not namedThymic extract (Russian); immunomodulator. Not on NCAA or WADA prohibited list. Distinct from Thymosin β4 (TB-500). | Not named | 34 |
|---|
| Pramlintide | Not named | Not namedFDA-approved amylin analog for diabetes. Not on NCAA or WADA prohibited list. | Not named | Not sold |
|---|
| Setmelanotide | Not named | Not namedFDA-approved MC4R agonist (rare genetic obesity). Not on NCAA/WADA list; therapeutic use documented. | Not named | Not sold |
|---|
| Survodutide | Not named | Not namedDual GLP-1/glucagon agonist (investigational). Not named on the NCAA or WADA 2026 Prohibited List.WADA: Not FDA-approved for human therapeutic use. WADA's S0 (Non-Approved Substances) category broadly covers unapproved investigational compounds like this one, even though it is not individually named on the Prohibited List. | Not named · S0 if unapproved | 19 |
|---|
| Mazdutide | Not named | Not namedDual GLP-1/glucagon agonist (investigational). Not named on the NCAA or WADA 2026 Prohibited List. | Not named | 17 |
|---|
| Boldenone Undecylenate | Banned | Named by NCAABoldenone explicitly named on NCAA Banned Drugs List under Anabolic Agents. | S1 · named | Not sold |
|---|
| Teriparatide | Not named | Named exceptionPTH 1-34 (osteoporosis, brand name Forteo). The NCAA's official banned-substances list names Forteo directly as an exception under Peptide Hormones, Growth Factors & Mimetics: "Insulin, Synthroid and Forteo are not banned." | Not named | Not sold |
|---|
| Pinealon | Not named | Not namedTripeptide bioregulator (Russian research); not on NCAA or WADA prohibited list.WADA: Not FDA-approved for human therapeutic use. WADA's S0 (Non-Approved Substances) category broadly covers unapproved investigational compounds like this one, even though it is not individually named on the Prohibited List. | Not named · S0 if unapproved | 67 |
|---|
| Orexin A | Not named | Not namedHypocretin wakefulness neuropeptide; not on NCAA or WADA prohibited list. Stimulant-adjacent mechanism but intranasal research doses are not prohibited by name.WADA: Not FDA-approved for human therapeutic use. WADA's S0 (Non-Approved Substances) category broadly covers unapproved investigational compounds like this one, even though it is not individually named on the Prohibited List. | Not named · S0 if unapproved | Not sold |
|---|
| ACE-031 | Banned | Class-basedActivin receptor IIB decoy / myostatin inhibitor; WADA S4.5 explicitly prohibits myostatin inhibitors. NCAA catchall applies. | S4 · named | 10 |
|---|
| Exenatide | Not named | Not namedGLP-1 agonist. Not named on the NCAA or WADA 2026 Prohibited List. | Not named | Not sold |
|---|
| Desmopressin | Banned | Class-basedSynthetic vasopressin analog; historically used as a plasma-volume masking agent to dilute EPO detection. Covered by WADA S5 Diuretics & Masking Agents / NCAA masking-agents catchall. | S5 · named | Not sold |
|---|
| Vasopressin | Not named | Not namedNative ADH (vasodilatory shock, diabetes insipidus). Not explicitly listed; therapeutic use. Desmopressin specifically is flagged as masking. | Not named | Not sold |
|---|
| Gonadorelin | Banned | Class-basedNative GnRH (LH-releasing hormone); NCAA catchall applies under hCG/LH-mimetic class. | S2 · named | 9 |
|---|
| Calcitonin | Not named | Not namedHypocalcemia / osteoporosis hormone. Not listed by NCAA/WADA. | Not named | Not sold |
|---|
| HMG (Human Menopausal Gonadotropin) | Banned | Class-basedLH/FSH mixture; NCAA explicitly bans hCG (same LH-mimetic class). Catchall applies. | S2 · named | 7 |
|---|
| Leuprolide | Banned | Class-basedGnRH agonist; WADA S2 prohibits GnRH analogues in males (stimulates LH/testosterone). NCAA catchall applies. | S2 · named | Not sold |
|---|
| Triptorelin | Banned | Class-basedGnRH agonist; WADA S2 prohibits GnRH analogues in males. NCAA catchall applies. | S2 · named | 1 |
|---|
| Degarelix | Not named | Not namedGnRH antagonist (prostate cancer). Lowers LH and testosterone rather than raising them. Not named by the NCAA, and WADA S2.2.1 covers only GnRH agonist analogues in males, so there is no clear banned-class fit. Corrected 2026-10-21 from an earlier banned call that cited WADA S2 for antagonists. | Not named | Not sold |
|---|
| Goserelin | Banned | Class-basedGnRH agonist; WADA S2 prohibits GnRH analogues in males. NCAA catchall applies. | S2 · named | Not sold |
|---|
| Relugolix | Not named | Not namedOral GnRH antagonist (prostate cancer, fibroids). Lowers LH and testosterone rather than raising them. Not named by the NCAA, and WADA S2.2.1 covers only GnRH agonist analogues in males, so there is no clear banned-class fit. Corrected 2026-10-21 from an earlier banned call that cited WADA S2 for antagonists. | Not named | Not sold |
|---|
| Buserelin | Banned | Class-basedGnRH agonist; WADA S2 prohibits GnRH analogues in males. NCAA catchall applies. | S2 · named | Not sold |
|---|
| Cetrorelix | Not named | Not namedGnRH antagonist (IVF). Lowers LH and testosterone rather than raising them. Not named by the NCAA, and WADA S2.2.1 covers only GnRH agonist analogues in males, so there is no clear banned-class fit. Corrected 2026-10-21 from an earlier banned call that cited WADA S2 for antagonists. | Not named | Not sold |
|---|
| Ganirelix | Not named | Not namedGnRH antagonist (IVF). Lowers LH and testosterone rather than raising them. Not named by the NCAA, and WADA S2.2.1 covers only GnRH agonist analogues in males, so there is no clear banned-class fit. Corrected 2026-10-21 from an earlier banned call that cited WADA S2 for antagonists. | Not named | Not sold |
|---|
| Nafarelin | Banned | Class-basedGnRH agonist; WADA S2 prohibits GnRH analogues in males. NCAA catchall applies. | S2 · named | Not sold |
|---|
| Histrelin | Banned | Class-basedGnRH agonist; WADA S2 prohibits GnRH analogues in males. NCAA catchall applies. | S2 · named | Not sold |
|---|
| Deslorelin | Banned | Class-basedVeterinary GnRH agonist; WADA S2 prohibits GnRH analogues in males. NCAA catchall applies. | S2 · named | Not sold |
|---|
| Alarelin | Banned | Class-basedVeterinary GnRH agonist; NCAA catchall applies (GnRH analog — LH stimulator). | S2 · class | Not sold |
|---|
| Fertirelin | Banned | Class-basedVeterinary GnRH agonist; NCAA catchall applies (GnRH analog — LH stimulator). | S2 · class | Not sold |
|---|
| Octreotide | Not named | Not namedSomatostatin analog — INHIBITS GH release. Not listed by NCAA/WADA (anti-doping in effect). | Not named | Not sold |
|---|
| Lanreotide | Not named | Not namedSomatostatin analog. Not listed by NCAA/WADA. | Not named | Not sold |
|---|
| Pasireotide | Not named | Not namedSomatostatin analog (Cushing's). Not listed by NCAA/WADA. | Not named | Not sold |
|---|
| Mecasermin | Banned | Named by NCAARecombinant IGF-1; NCAA explicitly names IGF-1. WADA S2.3 explicitly lists mecasermin. | S2 · named | Not sold |
|---|
| Lonapegsomatropin | Banned | Class-basedLong-acting pegylated hGH prodrug (FDA-approved); banned under NCAA growth hormone entry. | S2 · named | Not sold |
|---|
| Somapacitan | Banned | Class-basedLong-acting pegylated hGH analog (FDA-approved); banned under NCAA growth hormone entry. | S2 · named | Not sold |
|---|
| Glucagon | Not named | Not namedHyperglycemic rescue hormone. Not listed by NCAA/WADA. | Not named | Not sold |
|---|
| Glatiramer | Not named | Not namedRandom copolymer for multiple sclerosis. Not on NCAA or WADA prohibited list. | Not named | Not sold |
|---|
| Lixisenatide | Not named | Not namedGLP-1 agonist. Not named on the NCAA or WADA 2026 Prohibited List. | Not named | Not sold |
|---|
| Linzagolix | Not named | Not namedOral GnRH antagonist (uterine fibroids). Lowers LH and testosterone rather than raising them. Not named by the NCAA, and WADA S2.2.1 covers only GnRH agonist analogues in males, so there is no clear banned-class fit. Corrected 2026-10-21 from an earlier banned call that cited WADA S2 for antagonists. | Not named | Not sold |
|---|
| Elagolix | Not named | Not namedOral GnRH antagonist (endometriosis). Lowers LH and testosterone rather than raising them. Not named by the NCAA, and WADA S2.2.1 covers only GnRH agonist analogues in males, so there is no clear banned-class fit. Corrected 2026-10-21 from an earlier banned call that cited WADA S2 for antagonists. | Not named | Not sold |
|---|
| Carbetocin | Not named | Not namedOxytocin analog (postpartum hemorrhage). Not listed by NCAA/WADA. | Not named | Not sold |
|---|
| Atosiban | Not named | Not namedOxytocin receptor antagonist (preterm labor). Not listed by NCAA/WADA. | Not named | Not sold |
|---|
| Felypressin | Not named | Not namedVasopressin analog used as local-anesthetic vasoconstrictor. Not listed by NCAA/WADA. | Not named | Not sold |
|---|
| Lypressin | Not named | Not namedLysine vasopressin (diabetes insipidus). Not listed by NCAA/WADA. | Not named | Not sold |
|---|
| Ornipressin | Not named | Not namedVasopressin analog (hepatorenal syndrome). Not listed by NCAA/WADA. | Not named | Not sold |
|---|
| Argipressin | Not named | Not namedArginine vasopressin (same as native ADH). Not listed by NCAA/WADA. | Not named | Not sold |
|---|
| PNC-27 | Not named | Not namedp53-derived anticancer research peptide; not on NCAA or WADA prohibited list.WADA: Not FDA-approved for human therapeutic use. WADA's S0 (Non-Approved Substances) category broadly covers unapproved investigational compounds like this one, even though it is not individually named on the Prohibited List. | Not named · S0 if unapproved | 10 |
|---|
| PTD-DBM | Not named | Not namedCXXC5-Dvl disruptor research peptide (hair growth); not on NCAA or WADA prohibited list.WADA: Not FDA-approved for human therapeutic use. WADA's S0 (Non-Approved Substances) category broadly covers unapproved investigational compounds like this one, even though it is not individually named on the Prohibited List. | Not named · S0 if unapproved | 1 |
|---|
| B7-33 | Banned | Class-basedSingle-chain relaxin-2 mimetic peptide. Relaxin is a peptide hormone, so B7-33 fits the NCAA Peptide Hormones, Growth Factors & Mimetics catchall as a mimetic even though it is not individually named. | Not named · S0 if unapproved | 2 |
|---|
| Abaloparatide | Not named | Not namedPTH-related protein analog (osteoporosis). Not listed by NCAA/WADA; therapeutic only. | Not named | Not sold |
|---|
| Abarelix | Not named | Not namedGnRH antagonist (prostate cancer). Lowers LH and testosterone rather than raising them. Not named by the NCAA, and WADA S2.2.1 covers only GnRH agonist analogues in males, so there is no clear banned-class fit. Corrected 2026-10-21 from an earlier banned call that cited WADA S2 for antagonists. | Not named | Not sold |
|---|
| Plecanatide | Not named | Not namedGuanylate cyclase-C agonist (chronic constipation). Not listed by NCAA/WADA. | Not named | Not sold |
|---|
| Linaclotide | Not named | Not namedGuanylate cyclase-C agonist (IBS-C). Not listed by NCAA/WADA. | Not named | Not sold |
|---|
| Difelikefalin | Not named | Not namedPeripheral kappa-opioid agonist (uremic pruritus). Not listed by NCAA/WADA; structurally distinct from banned narcotics (non-CNS-penetrant). | Not named | Not sold |
|---|
| Nesiritide | Not named | Not namedRecombinant BNP (acute heart failure). Not listed by NCAA/WADA. | Not named | Not sold |
|---|
| Sincalide | Not named | Not namedCCK analog (diagnostic). Not listed by NCAA/WADA. | Not named | Not sold |
|---|
| Secretin | Not named | Not namedDiagnostic GI hormone. Not listed by NCAA/WADA. | Not named | Not sold |
|---|
| Pentagastrin | Not named | Not namedDiagnostic GI hormone (gastric acid). Not listed by NCAA/WADA. | Not named | Not sold |
|---|
| Protirelin | Not named | Not namedTRH (diagnostic). Not listed by NCAA/WADA. | Not named | Not sold |
|---|
| Corticotropin | Banned | Class-basedACTH; WADA S2.1 explicitly lists corticotropins (and its derivatives) as prohibited. NCAA catchall applies. | S2 · named | Not sold |
|---|
| Cosyntropin | Banned | Class-basedSynthetic ACTH analog (1-24 fragment); WADA S2.1 corticotropins. NCAA catchall applies. | S2 · named | Not sold |
|---|
| Relaxation PM Blend | Check ingredients | Check each ingredientProprietary sleep/recovery blend — status depends on component peptides (often melatonin, DSIP, GABA). Confirm each ingredient individually before use. | Depends on ingredients | Not sold |
|---|
| Dermorphin | Banned | Class-basedFrog-skin heptapeptide and potent mu-opioid receptor agonist. Not named by the NCAA, but it is pharmacologically related to the named narcotics (morphine, fentanyl), so it fits the NCAA narcotics class. WADA does not prohibit it in 2026; it is on the WADA Monitoring Program (in competition). | Monitoring only | 4 |
|---|
| RA-260 (ARA-290 high dose) | Banned | Class-basedSame compound as ARA-290 at research dose; banned under NCAA catchall (EPO-related). | S2 · class | Not sold |
|---|
| Vesugen | Not named | Not namedTripeptide vascular bioregulator; not on NCAA or WADA prohibited list.WADA: Not FDA-approved for human therapeutic use. WADA's S0 (Non-Approved Substances) category broadly covers unapproved investigational compounds like this one, even though it is not individually named on the Prohibited List. | Not named · S0 if unapproved | 9 |
|---|
| Daptomycin | Not named | Not namedLipopeptide antibiotic. Not on NCAA or WADA prohibited list. | Not named | Not sold |
|---|
| Vancomycin | Not named | Not namedGlycopeptide antibiotic. Not on NCAA or WADA prohibited list. | Not named | Not sold |
|---|
| Teicoplanin | Not named | Not namedGlycopeptide antibiotic. Not on NCAA or WADA prohibited list. | Not named | Not sold |
|---|
| Anidulafungin | Not named | Not namedEchinocandin antifungal. Not on NCAA or WADA prohibited list. | Not named | Not sold |
|---|
| Caspofungin | Not named | Not namedEchinocandin antifungal. Not on NCAA or WADA prohibited list. | Not named | Not sold |
|---|
| Micafungin | Not named | Not namedEchinocandin antifungal. Not on NCAA or WADA prohibited list. | Not named | Not sold |
|---|
| Enfuvirtide | Not named | Not namedHIV fusion inhibitor peptide (T-20). Not on NCAA or WADA prohibited list. | Not named | Not sold |
|---|
| Bivalirudin | Not named | Not namedDirect thrombin inhibitor (anticoagulant). Not listed by NCAA/WADA. | Not named | Not sold |
|---|
| Eptifibatide | Not named | Not namedGP IIb/IIIa antagonist (antiplatelet). Not listed by NCAA/WADA. | Not named | Not sold |
|---|
| Botulinum Toxin Type A | Not named | Not namedNeurotoxin (cosmetic / spasticity). Not on NCAA or WADA prohibited list. | Not named | Not sold |
|---|
| Ziconotide | Not named | Not namedN-type Ca channel blocker for chronic pain (intrathecal only). Not listed by NCAA/WADA; not a narcotic. | Not named | Not sold |
|---|
| Tesofensine | Banned | Class-basedNot named by the NCAA. Tesofensine blocks dopamine, norepinephrine and serotonin reuptake, the same action as the named stimulant methylphenidate, and WADA names it in S6.B as a stimulant. That is a clear fit for the NCAA stimulants class. | S6 · named | 7 |
|---|
| Adalank | Not named | Not namedMarketed modified Selank derivative. Not named by the NCAA, and like Selank it has no clear banned-class fit.WADA: Not approved for human therapeutic use, so WADA's S0 (Non-Approved Substances) category can apply to athletes in WADA-code testing. | Not named · S0 if unapproved | Not sold |
|---|
| AHK-Cu | Not named | Not namedCopper tripeptide (Ala-His-Lys) studied for hair follicles, a GHK-Cu relative. Not named by the NCAA or WADA, with no clear banned-class fit. | Not named | 45 |
|---|
| Testagen | Not named | Not namedTetrapeptide bioregulator (KEDG). Not named by the NCAA or WADA, with no clear banned-class fit.WADA: Not approved for human therapeutic use, so WADA's S0 (Non-Approved Substances) category can apply to athletes in WADA-code testing. | Not named · S0 if unapproved | 10 |
|---|
| Methylene Blue | Not named | Not namedRedox dye and FDA-approved methemoglobinemia treatment that also inhibits MAO-A. Not named by the NCAA or WADA, with no clear banned-class fit. | Not named | 1 |
|---|
| Cartalax | Not named | Not namedTripeptide bioregulator (Russian research); not on NCAA or WADA prohibited list. | Not named · S0 if unapproved | 25 |
|---|
| N-Acetyl Semax Amidate | Not named | Not namedSynthetic Semax analog; not named on NCAA or WADA lists, but WADA S0 (non-approved substances) catchall may apply — verify current list. | Not named · S0 if unapproved | 16 |
|---|
| N-Acetyl Selank Amidate | Not named | Not namedSynthetic Selank analog; not named on NCAA or WADA lists, but WADA S0 (non-approved substances) catchall may apply — verify current list. | Not named · S0 if unapproved | 15 |
|---|
| Vilon | Not named | Not namedDipeptide bioregulator (Russian research); not on NCAA or WADA prohibited list. | Not named · S0 if unapproved | 8 |
|---|
| Cortagen | Not named | Not namedTetrapeptide bioregulator (Russian research); not on NCAA or WADA prohibited list. | Not named · S0 if unapproved | 9 |
|---|
| Bronchogen | Not named | Not namedTetrapeptide bioregulator (Russian research); not on NCAA or WADA prohibited list. | Not named · S0 if unapproved | 7 |
|---|
| Cardiogen | Not named | Not namedTetrapeptide bioregulator (Russian research); not on NCAA or WADA prohibited list. | Not named · S0 if unapproved | 9 |
|---|
| Prostamax | Not named | Not namedTetrapeptide bioregulator (Russian research); not on NCAA or WADA prohibited list. | Not named · S0 if unapproved | 7 |
|---|
| Livagen | Not named | Not namedTetrapeptide bioregulator (Russian research); not on NCAA or WADA prohibited list. | Not named · S0 if unapproved | 6 |
|---|
| Ovagen | Not named | Not namedTripeptide bioregulator (Russian research); not on NCAA or WADA prohibited list. | Not named · S0 if unapproved | 4 |
|---|
| Pancragen | Not named | Not namedTetrapeptide bioregulator (Russian research); not on NCAA or WADA prohibited list. | Not named · S0 if unapproved | 5 |
|---|
| Chonluten | Not named | Not namedTripeptide bioregulator (Russian research); not on NCAA or WADA prohibited list. | Not named · S0 if unapproved | 3 |
|---|
| Thymogen | Not named | Not namedDipeptide bioregulator (Russian research); not on NCAA or WADA prohibited list. | Not named | 3 |
|---|
| Adalank Spray | Not named | Same as parentAlternate form of Adalank; the finding follows the compound, not the delivery route. | Not named · S0 if unapproved | 4 |
|---|
| Adamax | Not named | Not namedMarketed modified Semax derivative. Not named by the NCAA, and like Semax it has no clear banned-class fit.WADA: Not approved for human therapeutic use, so WADA's S0 (Non-Approved Substances) category can apply to athletes in WADA-code testing. | Not named · S0 if unapproved | 13 |
|---|
| Adamax Spray | Not named | Same as parentAlternate form of Adamax; the finding follows the compound, not the delivery route. | Not named · S0 if unapproved | 6 |
|---|
| BPC-157 + TB-500 + KPV | Banned | Blend: strictest partBlend of BPC-157, TB-500, KPV. It takes the strictest component finding, set by BPC-157. | S0 · named | 3 |
|---|
| BPC-157 Spray | Banned | Same as parentAlternate form of BPC-157; the finding follows the compound, not the delivery route. | S0 · named | 8 |
|---|
| CJC-1295 No DAC + Ipamorelin | Banned | Blend: strictest partBlend of CJC-1295 (No DAC), Ipamorelin. It takes the strictest component finding, set by CJC-1295 (No DAC). | S2 · named | 158 |
|---|
| CJC-1295 No DAC + Ipamorelin Spray | Banned | Blend: strictest partBlend of CJC-1295 (No DAC), Ipamorelin. It takes the strictest component finding, set by CJC-1295 (No DAC). | S2 · named | 1 |
|---|
| DSIP Spray | Not named | Same as parentAlternate form of DSIP (Delta Sleep-Inducing Peptide); the finding follows the compound, not the delivery route. | Not named · S0 if unapproved | 6 |
|---|
| GHK-Cu + KPV | Not named | Blend: strictest partBlend of GHK-Cu (Copper Peptide), KPV. It takes the strictest component finding, set by GHK-Cu (Copper Peptide). | Not named · S0 if unapproved | 6 |
|---|
| GHK-Cu Spray | Not named | Same as parentAlternate form of GHK-Cu (Copper Peptide); the finding follows the compound, not the delivery route. | Not named | 5 |
|---|
| GLOW Spray | Banned | Blend: strictest partBlend of BPC-157, TB-500, GHK-Cu (Copper Peptide). It takes the strictest component finding, set by BPC-157. | S0 · named | 1 |
|---|
| KLOW Spray | Banned | Blend: strictest partBlend of BPC-157, TB-500, GHK-Cu (Copper Peptide), KPV. It takes the strictest component finding, set by BPC-157. | S0 · named | 1 |
|---|
| KPV Spray | Not named | Same as parentAlternate form of KPV; the finding follows the compound, not the delivery route. | Not named · S0 if unapproved | 1 |
|---|
| Melanotan-2 Spray | Not named | Same as parentAlternate form of Melanotan-2 (MT-2); the finding follows the compound, not the delivery route. | Not named · S0 if unapproved | 5 |
|---|
| NAD+ Spray | Not named | Same as parentAlternate form of NAD+; the finding follows the compound, not the delivery route. | Not named · IV limit (M2.2) | 13 |
|---|
| Oxytocin Spray | Not named | Same as parentAlternate form of Oxytocin; the finding follows the compound, not the delivery route. | Not named | 4 |
|---|
| PT-141 Spray | Not named | Same as parentAlternate form of PT-141 (Bremelanotide); the finding follows the compound, not the delivery route. | Not named | 9 |
|---|
| GLP-3R + Cagrilintide | Not named | Blend: strictest partBlend of GLP-3R, Cagrilintide. It takes the strictest component finding, set by GLP-3R. | Not named · S0 if unapproved | 3 |
|---|
| Selank + Semax Spray | Not named | Blend: strictest partBlend of Selank, Semax. It takes the strictest component finding, set by Selank. | Not named | 4 |
|---|
| Selank Spray | Not named | Same as parentNasal-spray form of Selank. The finding follows the compound, not the delivery route: Selank is not named by the NCAA and has no clear banned-class fit. | Not named | 18 |
|---|
| Semax Spray | Not named | Same as parentNasal-spray form of Semax. The finding follows the compound, not the delivery route: Semax is not named by the NCAA and has no clear banned-class fit. | Not named | 17 |
|---|
| TB-500 Spray | Banned | Same as parentAlternate form of TB-500; the finding follows the compound, not the delivery route. | S2 · named | 3 |
|---|
| Tesamorelin + Ipamorelin | Banned | Blend: strictest partBlend of Tesamorelin, Ipamorelin. It takes the strictest component finding, set by Tesamorelin. | S2 · named | 15 |
|---|
| Thymulin | Not named | Not namedZinc-dependent thymic nonapeptide hormone. Not named by the NCAA. As a peptide hormone it may fall under the peptide hormones, growth factors, related substances and mimetics class, though it acts on immune cells rather than growth or muscle.WADA: Not approved for human therapeutic use, so WADA's S0 (Non-Approved Substances) category can apply to athletes in WADA-code testing. | Not named · S0 if unapproved | 4 |
|---|
| GLP-2T + GLP-3R | Not named | Blend: strictest partBlend of GLP-2T, GLP-3R. It takes the strictest component finding, set by GLP-2T. | Not named · S0 if unapproved | 1 |
|---|
| 9-ME-BC | Not named | Not named9-Methyl-β-carboline, a research compound studied for dopaminergic-neuron effects in cell and animal work. Not named by the NCAA, and no stimulant action is established in people.WADA: Not approved for human therapeutic use, so WADA's S0 (Non-Approved Substances) category can apply to athletes in WADA-code testing. | Not named · S0 if unapproved | 2 |
|---|
| Aniracetam | Not named | Not namedRacetam nootropic and AMPA-receptor modulator. Not named by the NCAA or WADA, and it has no stimulant or other banned-class pharmacology. | Not named | 2 |
|---|
| Bromantane | Banned | Class-basedNot named by the NCAA. WADA lists bromantan as a non-specified stimulant (S6.A), and it raises brain dopamine synthesis. As a substance pharmacologically related to the NCAA stimulants class, it falls under the related-substance rule. | S6 · named | 1 |
|---|
| Fasoracetam | Not named | Not namedInvestigational racetam (glutamate-receptor modulator). Not named by the NCAA, and it has no stimulant or other banned-class pharmacology.WADA: Never approved for human therapeutic use, so WADA's S0 (Non-Approved Substances) category can apply to athletes in WADA-code testing. | Not named · S0 if unapproved | 2 |
|---|
| Nefiracetam | Not named | Not namedInvestigational racetam. Not named by the NCAA, and it has no stimulant or other banned-class pharmacology.WADA: Never approved for human therapeutic use, so WADA's S0 (Non-Approved Substances) category can apply to athletes in WADA-code testing. | Not named · S0 if unapproved | 2 |
|---|
| Noopept | Not named | Not namedOmberacetam (GVS-111), a racetam-like dipeptide sold as a medicine in Russia. Not named by the NCAA or WADA, and it has no stimulant or other banned-class pharmacology. | Not named | 3 |
|---|
| Oxiracetam | Not named | Not namedRacetam nootropic. Not named by the NCAA or WADA, and it has no stimulant or other banned-class pharmacology. | Not named | 1 |
|---|
| Phenylpiracetam Hydrazide | Not named | Not namedNot named by the NCAA or WADA. It is the hydrazide of fonturacetam (4-phenylpiracetam), which WADA lists as a non-specified stimulant, so it may fall under the NCAA stimulants class as a chemically related substance. Its own stimulant effect has not been established. | Not named · S6 may apply | 2 |
|---|
| Piracetam | Not named | Not namedRacetam nootropic, approved as a medicine in several countries. Not named by the NCAA or WADA and not a stimulant (WADA names only the phenyl derivative fonturacetam). | Not named | Not sold |
|---|
| TAK-653 | Not named | Not namedInvestigational AMPA-receptor potentiator. Not named by the NCAA, and it has no stimulant or other banned-class pharmacology.WADA: Never approved for human therapeutic use, so WADA's S0 (Non-Approved Substances) category can apply to athletes in WADA-code testing. | Not named · S0 if unapproved | 1 |
|---|